Asthma Clinical Trial
Official title:
Improving Asthma Outcomes Through Cultural Competence Training for Physicians
The proposed randomized clinical trial will compare two educational interventions: Physicians Asthma Care Education (PACE) and PACE Plus with 90 physicians in Atlanta and the Bronx and their 1192 patients.
Massive resources are expended every year on cultural competence training for physicians.
However no rigorous study that has assessed whether cultural competence training for
physicians results in better health outcomes for their patients.
The investigators propose to conduct a randomized clinical trial to compare two
interventions. The study will involve three groups. The first, Physician Asthma Care
Education (PACE), is a proven program for enhancing communication, therapeutic practice and
the ability of physicians to foster effective management of asthma by their patients in
general. The second is the PACE program plus skills and concepts considered in the
literature essential to culturally competent practice (PACE PLUS). It is designed to give
clinicians a higher degree of certainty and confidence in working across cultures. PACE PLUS
was specifically developed to enable physicians to understand and overcome potential biases
in their interactions with patients whose racial/ethnic identity is different from their
own. The third is a control group that will not receive an intervention. Two racial/ethnic
groups of patients will be the focus of the research: African American and Latino/Hispanic,
specifically, Puerto Rican children with asthma and their parents or caretakers. The
proposed study will evaluate the effects of the training for physicians on health outcomes
for the children and performance ratings given to the physician by the parent of the child.
The proposed study will address two questions:
1. Does cultural competence training (PACE PLUS) produce better outcomes for minority
patients, specifically African American and Puerto Rican children, and their respective
parents, than a general communication training program (PACE)?
2. Compared to the control group, is the Physician Asthma Care Education program (PACE),
already shown to be effective with the general population of patients, effective when
used with minority patients, specifically African American and Puerto Rican children,
and their parents?
The study hypothesis is that there will be positive outcomes for patients of physicians in
both interventions but better outcomes for those patients whose doctors participate in the
cultural competence training (PACE PLUS). That is:
1. PACE PLUS compared to PACE will produce:
- reductions in children's health care use for asthma
- improved symptom experience for the children
- greater parent/caretaker satisfaction with the physician's performance
- enhanced asthma related quality of life for parents/caretakers of the patients
- higher levels of confidence and value placed by physicians on skills needed when
working cross culturally
- increased use of National Asthma Education and Prevention Program (NAEPP)
recommended therapies by physicians
2. PACE compared to a control group will produce better outcomes on these six dimensions.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|